Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

The ADAP Watch

April 13, 2012

 1  |  2  |  3  |  Next > 

Since the release of final FY2011 Ryan White grant awards in September 2011, including $40 million in ADAP emergency relief funding for 30 states with waiting lists or other cost-containment measures in place, some ADAPs were able to reduce the overall number of individuals on their waiting list. The number of individuals on waiting lists has decreased 67 percent since a high of 9,298 individuals on September 1, 2011.

Most states included on this ADAP Watch saw their waiting list numbers remain steady from last week's Watch, however, South Carolina's number decreased by 144 individuals due to cost savings from Medicare Part D wrap around payments and subsequent collection of rebate revenue, allowing re-enrollment of some individuals. Georgia's number increased by 62 individuals due to addition of new applicants to the program.

As states move individuals from their waiting lists into their ADAPs, new individuals continue to be enrolled and again added to their waiting lists. In addition, many ADAPs continue to struggle financially, including those without any cost-containment measures currently in place, and are beginning to anticipate the need for cost-containment measures and waiting lists in the new ADAP FY2012 grant year (began April 1, 2012). As a result of the variability of ADAP enrollment and funding, waiting lists will likely remain and continue to fluctuate until additional funding is received.

ADAP base and supplemental awards for FY2012, which include an additional $15 million appropriated by Congress, were recently issued to states. The Emergency Relief Funding (ERF) for ADAPs, including both the $35 million in new funding that President Obama announced on World AIDS Day and the $40 million in ERF continuation funding, has not yet been awarded. NASTAD understands that the distribution methodology for the $35 million in new funding will require ADAPs to apply and compete for the funding. The funding opportunity announcement (FOA) for both components of the ERF is expected to be released soon and awards are expected to be made in July 2012, although exact details are not available. NASTAD continues to advocate for thoughtful yet swift release of available funding as these awards will impact various cost-containment measures.

Finally, we have seen positive developments in the FY2013 budget for ADAP. President Obama's FY2013 budget proposal includes a $67 million increase for the AIDS Drug Assistance Program (ADAP) over FY2012 levels, for a total of $1 billion. The FY2012 ADAP earmark included in the FY2013 budget includes the $35 million announced on World AIDS Day.

To see information on pharmaceutical company co-payment assistance and patient assistance programs, please visit the Positively Aware website or the Fair Pricing Coalition's website.

 1  |  2  |  3  |  Next > 


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

This article was provided by National Alliance of State and Territorial AIDS Directors. Visit NASTAD's website to find out more about their activities and publications.
 
See Also
2012 National ADAP Monitoring Project Annual Report: Module One (PDF)
After Five Years, ADAP Waiting Lists Have Been Eliminated; Unmet Need and Funding Uncertainties Require Continued Commitment
More on ADAP Restrictions and Waiting Lists

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement